摘要
<span style="line-height:1.5;">Natural plant products have been used by the population of the south-eastern part of C</span><span lang="EN-US" style="line-height:1.5;">ô</span><span style="line-height:1.5;">te d’Ivoire in the management of sickle cell anemia. </span><span style="line-height:1.5;">This study was aimed at investigating the antisickling activity of the hydro-ethanolic extract </span><span "="" style="line-height:1.5;"><span>of a combination of the leaves of </span><i><span>J</span></i><span>. </span><i><span>secunda</span></i><span>, </span><i><span>J</span></i><span>. </span><i><span>gossypiifolia</span></i></span><span style="line-height:1.5;"> a</span><span "="" style="line-height:1.5;"><span>nd </span><i><span>P</span></i><span>. </span><i><span>nigrescens</span></i><span>.</span></span><span style="line-height:1.5;"> These three plants species were used in the Ivorian traditional herbal medicine. Preliminary phytochemistry was carried out using standard methods. As for the sickling reversal test, the Hb SS blood sickling was induced with 2% sodium metabisulfite. After 120 minutes of incubation, the plant extract was added. Every 30 minutes for a period of 120 minutes, a drop of the prepared solution was observed at (40</span><span style="line-height:1.5;">×</span><span "="" style="line-height:1.5;"><span>) magnification and the percentage of reversion calculated. The phytochemical analysis revealed the presence of Alkaloids, Flavonoids, Polyphenols, Catechic Tannins, Sterols and Polyterpenes. The results of the reversal test showed that the percentage of sickling reversal effect of the combination of the plants (75.00 ± 4.33</span><sup><span>b,c</span></sup><span>) was highly superior than the negative control (10.17 ± 0.55</span><sup><span>d</span></sup><span>) but was significantly (p < 0.05) the same as the percentage of the individual plant (</span><i><span>J</span></i><span>. </span><i><span>secunda</span></i><span>: 83.50 ± 2.33</span><sup><span>a</span></sup><span>;</span><i><span>J</span></i><span>. </span><i><span>gossypiifolia</span></i><span>: 78.00 ± 3.67</span><sup><span>b,c</span></sup><span> and </span><i><span>P</span></i><span>. </span><i><span>nigrescens</span></i><span>: 77.83 ± 2.89</span><sup><span>b,c</span></sup><span>) and the positive control (80.66 ± 2.22</span><sup><span>a,b</span></sup><span>). From the results, the extracts </span><i><span>J. secunda</span></i><span>, </span><i><span>J</span></i><span>. </span><i><span>gossypiifolia</span></i><span> and </span><i><span>P</span></i><span>. </span><i><span>nigrescens</span></i><span> have shown to be therapeutically beneficial to the population. Their use is also justified in the management of sickle cell disease in the south-eastern part of C</span></span><span lang="EN-US" style="line-height:1.5;">ô</span><span style="line-height:1.5;">te d’Ivoire.
<span style="line-height:1.5;">Natural plant products have been used by the population of the south-eastern part of C</span><span lang="EN-US" style="line-height:1.5;">ô</span><span style="line-height:1.5;">te d’Ivoire in the management of sickle cell anemia. </span><span style="line-height:1.5;">This study was aimed at investigating the antisickling activity of the hydro-ethanolic extract </span><span "="" style="line-height:1.5;"><span>of a combination of the leaves of </span><i><span>J</span></i><span>. </span><i><span>secunda</span></i><span>, </span><i><span>J</span></i><span>. </span><i><span>gossypiifolia</span></i></span><span style="line-height:1.5;"> a</span><span "="" style="line-height:1.5;"><span>nd </span><i><span>P</span></i><span>. </span><i><span>nigrescens</span></i><span>.</span></span><span style="line-height:1.5;"> These three plants species were used in the Ivorian traditional herbal medicine. Preliminary phytochemistry was carried out using standard methods. As for the sickling reversal test, the Hb SS blood sickling was induced with 2% sodium metabisulfite. After 120 minutes of incubation, the plant extract was added. Every 30 minutes for a period of 120 minutes, a drop of the prepared solution was observed at (40</span><span style="line-height:1.5;">×</span><span "="" style="line-height:1.5;"><span>) magnification and the percentage of reversion calculated. The phytochemical analysis revealed the presence of Alkaloids, Flavonoids, Polyphenols, Catechic Tannins, Sterols and Polyterpenes. The results of the reversal test showed that the percentage of sickling reversal effect of the combination of the plants (75.00 ± 4.33</span><sup><span>b,c</span></sup><span>) was highly superior than the negative control (10.17 ± 0.55</span><sup><span>d</span></sup><span>) but was significantly (p < 0.05) the same as the percentage of the individual plant (</span><i><span>J</span></i><span>. </span><i><span>secunda</span></i><span>: 83.50 ± 2.33</span><sup><span>a</span></sup><span>;</span><i><span>J</span></i><span>. </span><i><span>gossypiifolia</span></i><span>: 78.00 ± 3.67</span><sup><span>b,c</span></sup><span> and </span><i><span>P</span></i><span>. </span><i><span>nigrescens</span></i><span>: 77.83 ± 2.89</span><sup><span>b,c</span></sup><span>) and the positive control (80.66 ± 2.22</span><sup><span>a,b</span></sup><span>). From the results, the extracts </span><i><span>J. secunda</span></i><span>, </span><i><span>J</span></i><span>. </span><i><span>gossypiifolia</span></i><span> and </span><i><span>P</span></i><span>. </span><i><span>nigrescens</span></i><span> have shown to be therapeutically beneficial to the population. Their use is also justified in the management of sickle cell disease in the south-eastern part of C</span></span><span lang="EN-US" style="line-height:1.5;">ô</span><span style="line-height:1.5;">te d’Ivoire.
作者
Tatiana Kangah Mireille Kplé
Joel Akakpo-Akue
Julien Koffi Golly
Yvette Fofie
Marcel Gnamien Ahon
Mattieu Adou Kra
Ibrahime Sanogo
Antoinette Chiayé C. Yapo-Crezoit
Tatiana Kangah Mireille Kplé;Joel Akakpo-Akue;Julien Koffi Golly;Yvette Fofie;Marcel Gnamien Ahon;Mattieu Adou Kra;Ibrahime Sanogo;Antoinette Chiayé C. Yapo-Crezoit(Laboratory of Biology and Health, UFR Biosciences, Université Félix Houphouët-Boigny (UFHB), Abidjan, Côte d’Ivoire;Immunity Biology Center, Institut Pasteur de Côte d’Ivoire, Abidjan, Côte d’Ivoire;UFR of Pharmaceutical and Biological Sciences, Université Félix Houphouët-Boigny (UFHB), Abidjan, Côte d’Ivoire;Clinical Haematology Department, University Hospital of Yopougon, Abidjan, Côte d’Ivoire)
